Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F23975)

Formulation Name

Nilotinib Hydrochloride Monohydrate eq 150mg base capsule

Company

Novartis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nilotinib	DM7HXWT	Chronic myelogenous leukaemia	2A20.0	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Colcothar yellow	E00436	518696	Colorant
Crospovidone	E00626	Not Available	Disintegrant
Ferric oxide black	E00522	16211978	Colorant
Gelatin	E00630	Not Available	Other agent
Haematite red	E00236	14833	Colorant
Hydrophobic colloidal silica	E00285	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Poloxamer 188	E00645	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------